283 related articles for article (PubMed ID: 27759625)
21. Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication.
Hwang JJ; Lee DH; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Sep; 21(35):10234-41. PubMed ID: 26401089
[TBL] [Abstract][Full Text] [Related]
22. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial.
Ramas M; Donday MG; McNicholl AG; Gisbert JP
Gastroenterol Hepatol; 2017 Dec; 40(10):658-662. PubMed ID: 28780968
[TBL] [Abstract][Full Text] [Related]
24. Fourteen-day optimized levofloxacin-based therapy versus classical quadruple therapy for Helicobacter pylori treatment failures: a randomized clinical trial.
Cao Z; Chen Q; Zhang W; Liang X; Liao J; Liu W; Xiao S; Lu H
Scand J Gastroenterol; 2015; 50(10):1185-90. PubMed ID: 25881966
[TBL] [Abstract][Full Text] [Related]
25. A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy regimen achieves a high eradication rate as first-line anti-Helicobacter pylori treatment in Taiwan: a prospective randomized trial.
Tai WC; Liang CM; Kuo CM; Huang PY; Wu CK; Yang SC; Kuo YH; Lin MT; Lee CH; Hsu CN; Wu KL; Hu TH; Chuah SK
J Antimicrob Chemother; 2019 Jun; 74(6):1718-1724. PubMed ID: 30768161
[TBL] [Abstract][Full Text] [Related]
26. EFFICACY AND SAFETY OF GEMIFLOXACIN CONTAINING TREATMENT REGIMEN IN FIRST-LINE TREATMENT OF HELICOBACTER PYLORI.
Alanli R; Kucukay MB; Aydin MF; Ergül B; Yakaryilmaz F
Arq Gastroenterol; 2023; 60(3):350-355. PubMed ID: 37792765
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of 14-d vs 7-d moxifloxacin-based triple regimens for second-line Helicobacter pylori eradication.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 May; 21(18):5568-74. PubMed ID: 25987781
[TBL] [Abstract][Full Text] [Related]
28. Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients.
Gisbert JP; Pérez-Aisa A; Bermejo F; Castro-Fernández M; Almela P; Barrio J; Cosme A; Modolell I; Bory F; Fernández-Bermejo M; Rodrigo L; Ortuño J; Sánchez-Pobre P; Khorrami S; Franco A; Tomas A; Guerra I; Lamas E; Ponce J; Calvet X;
J Clin Gastroenterol; 2013 Feb; 47(2):130-5. PubMed ID: 22647827
[TBL] [Abstract][Full Text] [Related]
29. 10-Year Trends in Helicobacter pylori Eradication Rates by Sitafloxacin-Based Third-Line Rescue Therapy.
Mori H; Suzuki H; Matsuzaki J; Masaoka T; Kanai T
Digestion; 2020; 101(5):644-650. PubMed ID: 31387107
[TBL] [Abstract][Full Text] [Related]
30. Empirical Helicobacter pylori "rescue" therapy after failure of two eradication treatments.
Gisbert JP; Gisbert JL; Marcos S; Pajares JM
Dig Liver Dis; 2004 Jan; 36(1):7-12. PubMed ID: 14971810
[TBL] [Abstract][Full Text] [Related]
31. Amoxicillin, gemifloxacin and rabeprazole, as first-line Helicobacter pylori therapy in clinical practice: A pilot study.
Kilic G; Kilic GE; Özkahraman A; Konur S; Dertli R; Kayar Y
Medicine (Baltimore); 2024 May; 103(18):e38012. PubMed ID: 38701320
[TBL] [Abstract][Full Text] [Related]
32. Helicobacter pylori eradication with moxifloxacin-containing therapy following failed first-line therapies in South Korea.
Kang KK; Lee DH; Oh DH; Yoon H; Shin CM; Park YS; Kim N; Jung HC
World J Gastroenterol; 2014 Jun; 20(22):6932-8. PubMed ID: 24944485
[TBL] [Abstract][Full Text] [Related]
33. 'Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures.
Gisbert JP; Calvet X; Bujanda L; Marcos S; Gisbert JL; Pajares JM
Helicobacter; 2003 Apr; 8(2):90-4. PubMed ID: 12662375
[TBL] [Abstract][Full Text] [Related]
34. Third-line rescue therapy with levofloxacin after two H. pylori treatment failures.
Gisbert JP; Castro-Fernández M; Bermejo F; Pérez-Aisa A; Ducons J; Fernández-Bermejo M; Bory F; Cosme A; Benito LM; López-Rivas L; Lamas E; Pabón M; Olivares D;
Am J Gastroenterol; 2006 Feb; 101(2):243-7. PubMed ID: 16454825
[TBL] [Abstract][Full Text] [Related]
35. Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen.
Grimley CE; Penny A; O'sullivan M; Shebani M; Lismore JR; Cross R; Illing RC; Loft DE; Nwokolo CU
Aliment Pharmacol Ther; 1999 Jul; 13(7):869-73. PubMed ID: 10383520
[TBL] [Abstract][Full Text] [Related]
36. Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial.
Malfertheiner P; Bazzoli F; Delchier JC; Celiñski K; Giguère M; Rivière M; Mégraud F;
Lancet; 2011 Mar; 377(9769):905-13. PubMed ID: 21345487
[TBL] [Abstract][Full Text] [Related]
37. One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies.
Wong WM; Wong BC; Lu H; Gu Q; Yin Y; Wang WH; Fung FM; Lai KC; Xia HH; Xiao SD; Lam SK
Aliment Pharmacol Ther; 2002 Apr; 16(4):793-8. PubMed ID: 11929398
[TBL] [Abstract][Full Text] [Related]
38. Omeprazole-based dual and triple regimens for Helicobacter pylori eradication in children.
Kato S; Takeyama J; Ebina K; Naganuma H
Pediatrics; 1997 Jul; 100(1):E3. PubMed ID: 9200377
[TBL] [Abstract][Full Text] [Related]
39. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
Lee JM; Breslin NP; Hyde DK; Buckley MJ; O'Morain CA
Aliment Pharmacol Ther; 1999 Apr; 13(4):489-96. PubMed ID: 10215733
[TBL] [Abstract][Full Text] [Related]
40. Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication.
Yang JC; Wang HL; Chern HD; Shun CT; Lin BR; Lin CJ; Wang TH
Pharmacotherapy; 2011 Mar; 31(3):227-38. PubMed ID: 21361732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
